SSA
PTPI

Schonfeld Strategic Advisors’s Petros Pharmaceuticals PTPI Stock Holding History

Schonfeld Strategic Advisors’s Portfolio PTPI Stock Details PTPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-904
Closed -$31.9K – 2334
2023
Q4 		$31.9K Sell
904
-4
-0.4% -$143 ﹤0.01% 1683
2023
Q3 		$39.3K Sell
908
-20
-2% -$1.37K ﹤0.01% 1545
2023
Q2 		$47.1K Buy
+928
New +$72.3K ﹤0.01% 1818
2022
Q1 		– Sell
-1,372
Closed -$1.14M – 2859
2021
Q4 		$1.14M Buy
+1,372
New +$804K 0.01% 872

Other funds holding PTPI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
EL
EMFO LLC Weston, Florida $112M AUM 18.79% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return
NFSG
Newbridge Financial Services Group Boca Raton, Florida $608M AUM 31.28% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Schonfeld Strategic Advisors's PTPI Position: Q1 2024 in Review

Schonfeld Strategic Advisors sold out of Petros Pharmaceuticals (PTPI) in Q1 2024, closing a stake of 904 shares — an estimated $31.9K sold.

Schonfeld Strategic Advisors first reported a position in PTPI in Q4 2021 and held it in 4 quarters. The position peaked at $1.14M in Q4 2021. 10 funds tracked by Wall St. Rank hold PTPI as of Q1 2024.

  • Schonfeld Strategic Advisors reported no remaining Petros Pharmaceuticals position as of Q1 2024 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 904 Petros Pharmaceuticals shares in Q1 2024, an estimated $31.9K.
  • Schonfeld Strategic Advisors first reported a position in Petros Pharmaceuticals in Q4 2021 and held it in 4 quarters.
  • Schonfeld Strategic Advisors's Petros Pharmaceuticals position peaked at $1.14M in Q4 2021.
  • 10 funds tracked by Wall St. Rank held Petros Pharmaceuticals as of Q1 2024.

Based on Schonfeld Strategic Advisors's 13F filing for Q1 2024, filed 15 May 2024.